AQUAX2, NCT05926765: A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia |
|
|
| Recruiting | 2 | 120 | Europe, Canada, US | AAV2-hAQP1 Concentration 1, AAV2-hAQP1 Concentration 2, Placebo | MeiraGTx, LLC | Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands | 07/25 | 07/25 | | |